UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Biomarkers and personalised medicine in rheumatoid arthritis: a proposal for interactions between academia, industry and regulatory bodies

Annals of the Rheumatic Diseases, 2011-10, Vol.70 (10), p.1713-1718

2011

Volltextzugriff (PDF)

Candidate biomarkers for the diagnosis and prognosis of drug‐induced liver injury: An international collaborative effort

Hepatology (Baltimore, Md.), 2019-02, Vol.69 (2), p.760-773

2019

Volltextzugriff (PDF)

Recommendations for the registration of agents for prevention and treatment of glucocorticoid-induced osteoporosis: an update from the Group for the Respect of Ethics and Excellence in Science

Osteoporosis international, 2008-09, Vol.19 (9), p.1247-1250

2008

Volltextzugriff (PDF)

European regulatory perspectives for innovative therapies

Osteoporosis international, 2008-06, Vol.19 (6), p.725-731

2008

Volltextzugriff (PDF)

Use of Hy's Law and a New Composite Algorithm to Predict Acute Liver Failure in Patients With Drug-Induced Liver Injury

Gastroenterology (New York, N.Y. 1943), 2014-07, Vol.147 (1), p.109-118.e5

2014

Volltextzugriff (PDF)

Recommendations for the registration of agents for prevention and treatment of glucocorticoid-induced osteoporosis: an update from the Group for the Respect of Ethics and Excellence in Science

Osteoporosis international, 2009-03, Vol.20 (3), p.497-498

2009

Volltextzugriff (PDF)

An open, randomized, controlled study of transdermal hormone replacement therapy on the rate of bone loss in primary biliary cirrhosis

Journal of internal medicine, 2004-07, Vol.256 (1), p.63-69

2004

Volltextzugriff (PDF)

Clinical evaluation of medicinal products for acceleration of fracture healing in patients with osteoporosis

Bone (New York, N.Y.), 2008-08, Vol.43 (2), p.343-347

2008

Volltextzugriff (PDF)

Low body mass index and use of corticosteroids, but not cholestasis, are risk factors for osteoporosis in patients with chronic liver disease

Journal of hepatology, 1999-07, Vol.31 (1), p.84-90

1999

Volltextzugriff (PDF)

Evaluation of in vivo immune complex formation and complement activation in patients receiving intravenous Streptokinase

Clinical and experimental immunology, 1993-11, Vol.94 (2), p.286-290

1993

Volltextzugriff (PDF)

Biomarkers and personalised medicine in rheumatoid arthritis: a proposal for interactions between academia, industry and regulatory bodies

Annals of the rheumatic diseases, 2011, Vol.70 (10), p.1715-1720

2011

Volltextzugriff (PDF)

Critical issues in translational and clinical research for the study of new technologies to enhance bone repair

Journal of bone and joint surgery. American volume, 2008-02, Vol.90 Suppl 1 (Supplement_1), p.43-47

2008

Volltextzugriff (PDF)

Longitudinal bone loss in postmenopausal women with primary biliary cirrhosis and well‐preserved liver function

Journal of internal medicine, 2002-12, Vol.252 (6), p.537-541

2002

Volltextzugriff (PDF)

Inverse relationship between circulating levels of leptin and bone mineral density in chronic liver disease

Journal of gastroenterology and hepatology, 2001-12, Vol.16 (12), p.1409-1414

2001

Volltextzugriff (PDF)

Evrópufaraldur lifrarbólgu A á Íslandi árið 2017. Algengar breytingar í gallblöðru á myndgreiningu

Laeknabladid, 2018-06, Vol.2018 (6), p.283-287

2018

Volltextzugriff (PDF)

Increased rate of bone loss at the femoral neck in patients with chronic liver disease

European journal of gastroenterology & hepatology, 2002-01, Vol.14 (1), p.43-48

2002

Volltextzugriff (PDF)

Circulating levels of insulin-like growth factors and their binding proteins in patients with chronic liver disease: lack of correlation with bone mineral density

Liver (Copenhagen), 2001-04, Vol.21 (2), p.123-128

2001

Volltextzugriff (PDF)

Biochemical Markers of Musculoskeletal Health and Aging to be Assessed in Clinical Trials of Drugs Aiming at the Treatment of Sarcopenia: Consensus Paper from an Expert Group Meeting Organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the Centre Académique de Recherche et d'Expérimentation en Santé (CARES SPRL), Under the Auspices of the World Health Organization Collaborating Center for the Epidemiology of

Calcified tissue international, 2023-02, Vol.112 (2), p.197-217

2023

Volltextzugriff (PDF)

Causality Assessment for Suspected DILI During Clinical Phases of Drug Development

Drug safety, 2014-11, Vol.37 (Suppl 1), p.47-56

2014

Volltextzugriff (PDF)

Correction: Biochemical Markers of Musculoskeletal Health and Aging to be Assessed in Clinical Trials of Drugs Aiming at the Treatment of Sarcopenia: Consensus Paper from an Expert Group Meeting Organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the Centre Académique de Recherche et d'Expérimentation en Santé (CARES SPRL), Under the Auspices of the World Health Organization Collaborating Center for the Epid

Calcified tissue international, 2023-09, Vol.113 (3), p.357-358

2023

Volltextzugriff (PDF)

Real-world evidence: new opportunities for osteoporosis research. Recommendations from a Working Group from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)

Osteoporosis international, 2023-08, Vol.34 (8), p.1283-1299

2023

Volltextzugriff (PDF)

European outbreak of Hepatitis A in Iceland in 2017. Common radiological changes of the gallbladder

Laeknabladid, 2018-06, Vol.104 (6), p.283-287

2018

Volltextzugriff (PDF)

Hepatotoxicity associated with the use of Herbalife

Laeknabladid, 2010-03, Vol.96 (3), p.167

2010

Volltextzugriff (PDF)

Recommendations for an update of 2003 European regulatory requirements for registration of drugs to be used in the treatment of RA

Current medical research and opinion, 2011-02, Vol.27 (2), p.315-325

2011

Volltextzugriff (PDF)

Lifrarskaði tengdur notkun á Herbalife

Laeknabladid, 2010-03, Vol.2010 (3), p.167-172

2010

Volltextzugriff (PDF)

1 – 25 von 26

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(24)
Mit Volltextzugriff
(22)

Publikationsform

Artikel
(25)
Dissertationen
(1)

Sprache

Englisch
(24)
Isländisch
(2)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(20)
Science & Technology
(20)
Humans
(19)
Medical Sciences
(13)
Biological And Medical Sciences
(12)
Female
(11)
General & Internal Medicine
(11)
Adult
(10)
Human Health Sciences
(10)
Sciences De La Santé Humaine
(10)
Male
(9)
Middle Aged
(9)
Bone Density
(8)
Diseases Of The Osteoarticular System
(8)
Medicine
(8)
Orthopedics
(8)
Aged
(7)
Médecine Générale & Interne
(7)
Osteoporosis
(7)
Endocrinology
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Biomarkers and personalised medicine in rheumatoid arthritis: a proposal for interactions between academia, industry and regulatory bodies

Candidate biomarkers for the diagnosis and prognosis of drug‐induced liver injury: An international collaborative effort

Recommendations for the registration of agents for prevention and treatment of glucocorticoid-induced osteoporosis: an update from the Group for the Respect of Ethics and Excellence in Science

European regulatory perspectives for innovative therapies

Use of Hy's Law and a New Composite Algorithm to Predict Acute Liver Failure in Patients With Drug-Induced Liver Injury

Recommendations for the registration of agents for prevention and treatment of glucocorticoid-induced osteoporosis: an update from the Group for the Respect of Ethics and Excellence in Science

An open, randomized, controlled study of transdermal hormone replacement therapy on the rate of bone loss in primary biliary cirrhosis

Clinical evaluation of medicinal products for acceleration of fracture healing in patients with osteoporosis

Low body mass index and use of corticosteroids, but not cholestasis, are risk factors for osteoporosis in patients with chronic liver disease

Evaluation of in vivo immune complex formation and complement activation in patients receiving intravenous Streptokinase

Biomarkers and personalised medicine in rheumatoid arthritis: a proposal for interactions between academia, industry and regulatory bodies

Critical issues in translational and clinical research for the study of new technologies to enhance bone repair

Longitudinal bone loss in postmenopausal women with primary biliary cirrhosis and well‐preserved liver function

Inverse relationship between circulating levels of leptin and bone mineral density in chronic liver disease

Evrópufaraldur lifrarbólgu A á Íslandi árið 2017. Algengar breytingar í gallblöðru á myndgreiningu

Increased rate of bone loss at the femoral neck in patients with chronic liver disease

Circulating levels of insulin-like growth factors and their binding proteins in patients with chronic liver disease: lack of correlation with bone mineral density

Causality Assessment for Suspected DILI During Clinical Phases of Drug Development

Real-world evidence: new opportunities for osteoporosis research. Recommendations from a Working Group from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)

European outbreak of Hepatitis A in Iceland in 2017. Common radiological changes of the gallbladder

Hepatotoxicity associated with the use of Herbalife

Recommendations for an update of 2003 European regulatory requirements for registration of drugs to be used in the treatment of RA

Lifrarskaði tengdur notkun á Herbalife

Suchergebnisse filtern